

[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI
[ Mon, Apr 27th 2020
] - WOPRAI

[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
[ Fri, Apr 24th 2020
] - WOPRAI
Sumant Kulkarni Maintained (BIIB) at Strong Buy with Decreased Target to $350 on, Apr 24th, 2020
Sumant Kulkarni of Canaccord Genuity, Maintained "Biogen Inc." (BIIB) at Strong Buy with Decreased Target from $360 to $350 on, Apr 24th, 2020.
Sumant has made no other calls on BIIB in the last 4 months.
There are 12 other peers that have a rating on BIIB. Out of the 12 peers that are also analyzing BIIB, 4 agree with Sumant's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Evan Seigerman of "Credit Suisse" Maintained at Hold with Decreased Target to $310 on, Thursday, April 23rd, 2020
- Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $316 on, Tuesday, February 25th, 2020
- Alethia Young of "Cantor Fitzgerald" Reiterated at Hold with Increased Target to $361 on, Thursday, February 6th, 2020
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $311 on, Thursday, February 6th, 2020
These are the ratings of the 8 analyists that currently disagree with Sumant
- Carter Gould of "Barclays" Maintained at Buy with Decreased Target to $370 on, Thursday, April 23rd, 2020
- Jay Olson of "Oppenheimer" Maintained at Buy with Decreased Target to $365 on, Thursday, April 23rd, 2020
- Matthew Harrison of "Morgan Stanley" Maintained at Sell with Decreased Target to $301 on, Thursday, April 23rd, 2020
- Robyn Karnauskas of "SunTrust Robinson Humphrey" Maintained at Strong Buy with Decreased Target to $330 on, Thursday, April 23rd, 2020
- Steven Seedhouse of "Citigroup" Downgraded from Hold to Strong Sell on, Thursday, April 23rd, 2020
- Christopher Marai of "Nomura" Maintained at Strong Buy with Increased Target to $392 on, Friday, February 7th, 2020
- Brian Skorney of "Baird" Maintained at Sell with Increased Target to $290 on, Thursday, February 6th, 2020
- Marc Goodman of "SVB Leerink" Maintained at Buy with Increased Target to $410 on, Thursday, February 6th, 2020
Contributing Sources
Similar Stocks and Investing Articles
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Apr 23rd 2020
] - WOPRAI
[ Thu, Feb 27th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Fri, Feb 07th 2020
] - WOPRAI